Tilray in Polish pharmacies: fourteen strains from the Portuguese facility and two products named Sirius

Who is Tilray and where does the raw material supplied to Polish pharmacies come from?

Tilray is a company founded in Canada in 2013, now part of the publicly traded Tilray Brands group in the United States. However, the raw material sold in Polish pharmacies under this label comes from Europe: the pharmaceutical base is provided by Tilray Portugal, a company operating a facility in Cantanhede.

The path from the Canadian startup to today's group was through an acquisition. In December 2020, Aphria conducted a reverse acquisition of Tilray, and the combined entity continues to operate under the name Tilray Brands, headquartered in New York. The company's materials mention cultivation and production in Canada, Germany, and Portugal, and good manufacturing practice certificates are attributed to the facilities in Nanaimo and Cantanhede. For the Polish patient, only the latter matters, as its name appears in the description of the pharmacy product.

The presence in the Polish market has a date. In August 2022, the company announced that the Ministry of Health allowed its dried flower for pharmacy circulation alongside an earlier wholesale permit, and announced cooperation with several pharmaceutical partners on both branded and unbranded products. What we have not established: when the first packages actually appeared on pharmacy shelves and which entity is listed in the Polish register as responsible for these products. We did not open the register at the source, so we will not make such a statement here.

Which Tilray strains are available in Polish pharmacies?

Fourteen. The list of pharmacy products associated with this cluster includes fourteen strains and eighteen separate items, as four names appear in two declared strength variants. This is the second result among sixteen manufacturers in the ranking, after S-LAB with thirty-eight strains.

The leading terpene is evenly distributed among these fourteen: myrcene, caryophyllene, and nerolidol each lead with four names, while pinene and terpinolene have one each. This assignment comes from the pharmacy list and indicates which note the list's editorial team considered primary. It is not the result of sample analysis and does not refer to any specific batch.

Four names appear twice in the list, in two variants of declared strength: Cataract Kush, Island Sweet Skunk, Lilac Diesel, and Pink Kush. This explains the difference between the fourteen strains and the eighteen entries. For the reader, this has one practical consequence: two entries with the same strain name are not the same prescription.

Thirteen of these fourteen names also appear in the list under the S-LAB label, nine under Synoptis Pharma, and Pink Kush has a total of five, as Aurora and Polfarmex are also included. Only Tilray Sirius appears in the list under a single label. The assortment changes from delivery to delivery and is not a characteristic of the strain, so we keep the current state in one place, in a comprehensive overview of available strains. Dried flower sold over the counter is a different category of product than pharmacy-grade material and is listed in the store under the dried flower category.

Does the same dried flower appear in pharmacies under several labels?

Probably yes, although we cannot confirm this with documentation. The database from which we derive pharmacy-grade composition states directly for the Blueberry entry that the same facility produces dried flower sold under the S-LAB brand, and refers to both labels as having a common origin. Formally, however, they remain separate pharmaceutical materials.

A second source states the same from the S-LAB product side: it is released on the Polish market by an entity of that name, and produced in Portugal by Tilray Portugal. An industry portal reported in October 2023 about three trade names for one raw material, adding to the previous two entries those sold by Polfarmex. None of these statements come from the registry or from a batch release document, so we treat them as industry reports rather than established facts.

On the pharmacy counter, the difference is clear. A service for pharmacists responded in July 2023 that a prescription issued for S-LAB dried flower entitles the dispensing of S-LAB dried flower, while a prescription for Tilray entitles the dispensing of Tilray, despite identical declared content, because we are talking about separate materials from separate entities, and the possibility of substitution is not provided here. Therefore, the number sixteen in this cluster refers to the number of names on the labels, not the number of facilities where the material is grown. How many of the latter there are is not indicated by the available records.

Why does the name Sirius appear twice in this list?

Because there are two separate entries under it in the pharmacy list: one with the Tilray label, the other with the S-LAB label. The project treats them as two different cultivars, and each receives its own entry. They only share the word in the name and the leading terpene assigned in the list, which is caryophyllene.

The chapter is not a coincidence. Our breakdown of labels removes from the name the part that is the manufacturer's name, so the entry described in the list as Tilray Blueberry ends up in the list simply as Blueberry. Tilray Sirius is on a clear list of exceptions, where the word matching the manufacturer's name is part of the strain name itself, just like with Aurora Indica. The list is maintained manually and is intentionally incomplete, as such a case cannot be resolved from the label alone.

The material for both products is different. The Tilray product has recorded parents in the pedigree chart: chemdawg and alien tech, and sources describe the name Sirius as a trade designation for a strain previously known as Alien Dawg. The S-LAB product has no established origin. Each also carries its own potency declaration, and combining them under one key has already resulted in one of them having a false range, glued together from the declarations of two different companies. Separate entries describe the Tilray product and the S-LAB product. None of the collected records confirm or exclude the identity of the plant material between them.

How does Tilray's raw material differ from that of other producers?

The most noticeable difference is the name of the product. In the registered name of Tilray's dried flower, there is no strain name: the pharmacy base shows only the name Cannabis flos Tilray with the declared content numbers. For some other entities, the strain name is directly included in the product name, as is the case with Synoptis Pharma's dried flower.

For the patient, this is not a mere editorial detail. From the name on the prescription and the packaging, it is impossible to determine which strain is contained in the bag. An industry portal stated in 2023 that the strain is recognized by the letters in the batch number, which we did not verify on the packaging. However, the form is consistently stated: dried flower in a fifteen-gram zip bag.

The rest of the differences break down into fact and marketing material. The manufacturer is listed in the pharmacy database, and it is clear that we are talking about a pharmaceutical raw material dispensed by prescription, not a finished drug. The company's communications mention a good manufacturing practice certificate for the facility in Portugal and deliveries to the EU from the Portuguese and German facilities, but these are its own statements repeated by industry media, not a document we opened. Terms like the first certified hemp company or international giant describe the market position and say nothing about the quality of a single batch.

What is known and what is not known about the raw material from this producer?

It is known where the raw material is produced and in what form it is dispensed. It is unknown what a single batch contains: for none of the fourteen strains did we find a publicly available certificate of analysis, and the descriptions of the terpene profiles come from Polish consumer services, not from the entity producing the raw material.

The state of these descriptions can be quantified. Two services from which the cluster takes profiles describe a total of seven out of fourteen strains, and the composition matches only for one of them; for the other six, they provide differing sets. Another seven strains have a description in one service. The declared genetics diverges among sources for seven names, and the origin cannot be established for five. None of these numbers describes Tilray's raw material: they describe the strain names under which this raw material is sold.

Separately stands what is a relation. Descriptions of aroma, potency, and time of day circulating on store blogs and patient forums are not documentation; they arise from individual experiences and lack a protocol that could be repeated. The declared content of active substances is also a declaration with a margin, not a measurement of a specific bag. None of this is a complaint against the producer: this is how data availability looks across the entire market, not just for one label.

What adverse effects have been reported after using this producer's raw material?

None that could be attributed specifically to this label. Public compilations of reports are not broken down by individual producers in Poland, so there is simply no list of symptoms for Tilray's products. Below is a description referring to the entire group of this raw material, not to one label.

Reports of adverse effects are collected for medicinal products with a batch number, not for the strain name, so the following pertains to hemp dried flower as a group of raw materials. The most frequently reported symptoms are dry mouth, red eyes, and increased heart rate. Dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory are less frequently described, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp dried flower in Poland do not separate them by individual products.

The practical conclusion is clear: a report has value when it carries the batch number from the packaging, as it identifies the batch, not the strain name or the writing on the label. Discussions about symptoms should be held with the attending physician or pharmacist, not with a strain description found online.

Frequently Asked Questions

Who produces the dried flower sold in Poland under the Tilray label?

Pharmacy databases list the manufacturer as Tilray Portugal, a company operating a facility in Cantanhede, Portugal. The Tilray Brands group itself has Canadian roots and is headquartered in the United States, but the raw material for Polish pharmacies comes from Europe.

How many Tilray strains are available in Polish pharmacies?

Fourteen strains and eighteen separate products, as four names appear in two variants of declared potency. This is the second result among sixteen producers in this compilation. The assortment changes from delivery to delivery, so the current state is checked in the aggregate list of strains.

Is Tilray's dried flower the same raw material as S-LAB's?

Industry services state that both come from the same facility in Portugal, but they are registered as separate pharmaceutical raw materials. We did not open the document confirming the identity of the plant material, so the question remains unresolved.

Can a pharmacist dispense Tilray's dried flower instead of S-LAB's?

No. The service for pharmacists stated in 2023 that a prescription written for one dried flower is dispensed as that specific dried flower, despite identical declared content, because hemp dried flowers are pharmaceutical raw materials, not finished drugs, and substitution is not provided for.

How does Sirius differ from Tilray Sirius?

These are two separate pharmacy products from different companies, listed in this compilation as two cultivars. The Tilray product has a recorded pedigree, while the S-LAB product does not have an established origin. The commonality is the word in the name and the leading terpene assigned in the list.

Does Synoptis Pharma sell dried flower from Tilray?

An industry portal reported in 2025 that Synoptis Pharma from the Neuca group registered two products together with Tilray and is involved in distributing products of this brand. However, in the pharmacy database, Synoptis Pharma's products have their own manufacturer listed.

Does Tilray publish certificates of analysis for Polish products?

We did not find publicly available certificates of analysis for products sold in Polish pharmacies. This does not mean that tests are not conducted at all; it means that patients do not have public access to their results.

Hemp dried flower is a pharmaceutical raw material dispensed by prescription in the Rpw category. The material is informational in nature and does not replace consultations with the attending physician or advice from a pharmacist.

Editorial text: redakcja ubucha.pl.